Bile Acids Flashcards
Describe the production of bile acids. What pathways are involved?
•Produced from cholesterol in hepatocytes
• Classic pathway (produces Cholic Acid; CA) and Alternative pathway (produces Chenodeoxycholic Acid; CDCA)
- each pathway has their own rate limiting enzyme
What is the difference between bile acids and bile salts?
Primary bile acids are conjugated with either TAURINE or GLYCINE (++) to form bile salt before they are secreted from hepatocytes
Give the 4 general steps in enterohepatic circulation
- Bile salts are secreted by liver - 95% are old, recycled bile salts; 5% are newly synthesized
- 95% of bile salts are reabsorbed by the small intestine
- Reabsorbed bile salts travel through portal vein to be recycled by liver
- 5% of bile salts are lost in feces
How do gut microbiota modify bile salts?
A small amount of bile salts will be de-conjugated and modified by microbiota (dehydrogenation, dehydroxylation, epimerization, etc) to produce secondary bile acids
- mainly deoxycholic acid (DCA) and litocholic acid (LCA)
How do enterocytes reabsorb bile salts/bile acids on their apical side?
- Bile salt - Via ASBT (apical sodium dependent bile salt transporter)
- Bile acids - Passive diffusion
Once bile salts/acids are inside enterocytes what happens?
- Activate FXR (farnesoid X receptor), a nuclear receptor, to produce FGF 19 (fibroblast growth factor 19) - a hormone-like protein, which is secreted out of entercytes and enters portal vein
- Bile salts transported out of enterocyte by transporter and enter portal vein
Describe FXR in enterocytes and why it’s important
A nuclear receptor in enterocytes that is activated by bile acids/salts and produces FGF15/19, a hormone-like protein that goes into circulation
What happens when bile salts/acids return to liver?
Taken up by heptaocytes via transporters and activate FXR there to produce SHP-1, which inhibits expression of the rate-limiting enzyme for the Classic bile synthesis pathway
- suppresses bile acid generation from cholesterol
- thereby maintaining homeostasis
What happens when FGF15/19 reaches liver?
• Acts on hepatocyte and induces intracellular signalling events that can inhibit conversion of cholesterol to bile acids
Briefly describe the direct and indirect mechanism of bile acid/salt metabolic regulation
DIRECT - Bile acid-regulated signaling pathways, FXR and TGR5 (transmembrane G-protein-coupled receptor 5)
INDIRECT - FGF15/19 generated by enterocytes
**not limited to liver because bile acid can escape circulation and go anywhere - skeletal muscle, adipose tissue, etc
Name two direct effects FXR can have on the body’s metabolism
- Negatively regulate bile acid pool during synthesis and increase bile acid export
- Regulate lipid metabolism and gluconeogenesis
How does bile acid lower hepatic TAG levels via FXR?
- FXR inhibits SREB-1C (master regulator of de novo lipogenesis) expression by up-regulating SHP-1
- This decreases hepatic TAG synthesis and VLDL secretion
How does FXR affect gluconeogenesis in liver?
- Inhibits PEPCK and Glucose-6-phosphatase (two rate-limiting enzymes in glycolysis pathway) via upregulating SHP-1
- Bile acids activate FXR, and therefore suppress gluconeogenesis in liver (alleviating fasting hyperglycemia in liver)
Where can TGR5 activation happen? Briefly describe the effects
• SKELETAL MUSCLE and BROWN ADIPOSE TISSUE - activates deiodinase DIO2, which generates T3 (active thyroid hormone)
- increased energy expenditure
• INTESTINAL LUMEN - bile acids activate TGR5 in enteroendocrine cells, resulting in release of incretin GLP-1
- increased insulin secretion and/or sensitivity
• KUPFFER CELLS and MACROPHAGES - TGR 5 activation inhibits LPS-induced cytokine production
- decreased inflammation
What are the indirect effects of bile salts on the liver. What plays a role in this?
**Via FGF15/19 production
- Decreased lipogenesis
- Increased glycogen storage
- Decreased gluconeogenesis
- Decreased blie acid synthesis